(Q81771109)

English

Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c

scientific article published on 01 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Mycobacterium bovis

1 reference

based on heuristic

inferred from title

7

object named as

Lorne A Babiuk

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

H. Martin Vordermeier

1

object named as

H Martin Vordermeier

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Reno Pontarollo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Brenda Karvonen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Paul Cockle

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Rolf Hecker

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Mahavir Singh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

R Glyn Hewinson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Sylvia van Drunen Littel-van Den Hurk

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

4375-4384

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Living up to the legacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

TB vaccines: progress and problems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

The ESAT-6/WXG100 superfamily -- and a new Gram-positive secretion system?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

ProPred: prediction of HLA-DR binding sites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Induction of specific immune responses by polycation-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Central memory and effector memory T cell subsets: function, generation, and maintenance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Progressive differentiation and selection of the fittest in the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Prime-boost strategies for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Development of a DNA-MVA/HIVA vaccine for Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Developing an improved vaccine against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Synthetic peptide-based vaccine and diagnostic system for effective control of FMD

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.022

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.04.022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908057%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81771109&oldid=1796570274"